Background: Colorectal cancer (CRC) is one of the most common cancers all over the world, but its epidemiology is obviously different in various regions. Methods: The treatment of CRC also has varying characteristics due to differences in economy, geography, disease onset, chemotherapy, and other factors, although international guidelines are used to guide the treatment of CRC in China. Results: This paper summarizes the current status of CRC treatment, including surgical therapy, neoadjuvant radiotherapy and chemotherapy, postoperative chemotherapy, targeted therapy, maintenance therapy, and immunotherapy, according to the clinical situation in China, so as to provide better therapy and improve clinical practice for patients with CRC. Conclusion: This research shows that the treatment of colorectal cancer continues to progress, and the patient's efficacy and quality of life have improved.
[1]Tongji Univ, Dept VIP Clin, South Branch, Shanghai East Hosp, Shanghai, Peoples R China.
[2]Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai Med Coll, Shanghai, Peoples R China.
[3]Tongji Univ, Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China.
(8.0+极速模式)